However, the central gray of the midbrain, the nuclei of the reticular formation, brain stem regions projecting to the cerebellum, and cranial nuclei of the trigeminal and vagal nerves also exhibited intense glial labeling for GDH, even though some of these regions are known to receive only weak glutamatergic projections. A second factor determining the distribution of GDH appeared to be neuronal activity, as assessed by correspondence with reported high densities of cytochrome oxidase. We conclude that GDH enriched in glial populations (1) exists in a subcellular compartment distinct from that of neurons and (2) may serve as one of the enzymes involved in glutamatergic transmission. Deficiencies of glial GDH and the consequent cytotoxic effects of high levels of excitatory amino acids may contribute to a number of neurodegenerative disorders.
Glutamate dehydrogenase (GDH; L-glutamate : NAD oxidoreductase; E.C. 1.4.1.2) is one of the major enzymes involved in the interconversion of glutamate and alpha-ketoglutarate of the tricarboxylic acid cycle (Dennis and Clark, 1977) . Thus, GDH might be expected to be present in mitochondria of both glia and neurons throughout the brain. However, since glutamate is also an excitatory transmitter in selective neuronal pathways (Cotman et al., 198 1; Watkins and Evans, 198 1; Fonnum, 1984) higher concentrations of the enzyme also might be expected in corresponding neurons or their associated glia. The glial versus neuronal, or the dual glial and neuronal localization of GDH in brain has been contested for a number of years (see Nicklas, 1984 , for a review). Furthermore, the regional concentrations of GDH relative to glutamatergic pathways have not been extensively examined by cytochemical methods (Graham and Aprison, 1969; Ryder, 1980; Wenthold, 1980; Leong and Clark, 1984) .
In the present study we employed the peroxidase-antiperoxidase (PAP) immunocytochemical method (Stemberger, 1979) for determining the cellular and regional distributions of GDH in adult rat brain. The glial versus neuronal labeling was distinguished by the dual localization of GDH and of glial fibrillary acidic protein (GFAP) (Bignami et al., 1972) using combined PAP and immunoautoradiographic methods (Pickel et al., 1986) . Furthermore, since GDH is believed to exist in at least 2 forms, differing in susceptibilities to solubilization by detergents and salts (Colon et al., 1986; Lai et al., 1986) , we examined the immunocytochemical localization of the enzyme under a variety of fixation conditions, using different concentrations of detergents in the labeling procedure.
Materials and Methods
Antisera. The antiserum to GDH was prepared by immunizing rabbits with bovine liver GDH (Sigma) that had been further purified by SDS-PAGE. This antiserum has been tested for its specificity by the detection of a single immunoreactive material on immunoblots, using GDH purified from bovine liver, as well as GDH in whole homogenates of brain (Lai et al., 1986) .
Rabbit PAP and rabbit anti-GFAP antiserum were generously supplied bv the laboratories of Dr. T. H. Joh (Cornell Universitv Medical i?ollege, New York) and Drs. A. Bignami and D. Dahl (V. A. Medical Center, MA) , respectively. Donkey anti-rabbit rZSI-IgG was obtained from Amersham, and goat anti-rabbit IgG from Miles Laboratory (Elkhart, IN).
Fixation and sectioning. Thirty-two adult (180-250 gm) male rats were perfused for 6 min through the ascending aorta with one of 3 fixatives. These were (1) 200 ml of 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4); (2) 50 ml of 3.75% acrolein and 2% paraformaldehyde, followed by 150 ml of 2% parafotmaldehyde; and (3) 4% paraformaldehyde with 0.1-0.2% glutaraldehyde. After the termination of perfusion, the brains were removed, cut into 1 mm coronal or sagittal blocks and further fixed in 2 or 4% paraformaldehyde for r/z hr. With each of the 3 fixation conditions, the 1 mm blocks were sectioned at 30-50 pm on a Vibratome or were cryoprotected with 10% sucrose in 0.1 M phosphate buffer, rapidly frozen in freon, then sectioned on a sliding microtome. Both types of sections were collected in 0.1 M Tris-O.9% NaCl buffer (Tris-saline) at pH 7.6.
Single-labeling with the GDH and the GFAP antisera. The fixed sections were immunocytochemically labeled by a modification (Pickel, 198 1) of the PAP method of Stemberger (1979) . Prior to the incubation of sections with the antiserum, they were incubated for '/2 hr with 3% goat serum-Tris-saline.
This buffer, with the substitution of 3% goat serum with 1% goat serum, was used in all ofthe subsequent incubations and in the rinses between incubations. Sections were incubated with GDH or GFAP antiserum for a period of 12-48 hr and at dilutions from 1:800 to 1:5000. Sections were then incubated in the goat antirabbit IgG at a dilution of 1:50 for 1 hr, followed by an incubation in the rabbit PAP at a dilution of 1:lOO for 1 hr. Following 2 rinses in Tris-saline not containing goat serum, the peroxidase was demonstrated by reaction with 3',3'-diaminobenzidine and H,O, For the purpose of enhancing the penetration of the antisera, some sections were permeabilized with 0.25% (vol/vol) Triton X-100 or (Wu vol) saponin. In these cases, the detergent was added to all incubation and wash solutions. All incubations and washes were carried out at room temperature.
Preadsorption of the GDH-antiserum with GDH. Bovine liver GDH was coupled to cyanogen bromide-activated Sepharose 4B beads (Pharmacia), according to the manufacturer's instructions. Two milliliters of anti-GDH antiserum (ca. 40 pg of IgG, 40 mg of total protein) were incubated with 100 ~1 of GDH coupled to Sepharose beads (100 pg of GDH) for 1 hr at 37°C under gentle agitation. The supematant formed by a 1 min centrifugation at 100 x n was collected and substituted for the specific antiserum in the labeling procedure.
Dual labelinp for GDH and GFAP. The antisera to GDH and GFAP were raised in Tabbits. Thus, one antiserum had to be localized using a dilution sufficiently high to be recognized by autoradiography of 1251-labeled secondary antibody, but not by the peroxidase method, as was described recently in detail (Pickel et al., 1986) . The sections were first incubated with the GFAP antiserum at a dilution of 1:30,000, which was determined to be the highest possible dilution that allowed for reasonable detections of the immunoreactivity by autoradiography, but not by peroxidase. Following a 12-16 hr period of incubation with or without 0.25% Triton X-100, sections were incubated in a buffer containing a 1:50 dilution of donkey anti-rabbit Y-IgG (100 pCi/ml) for 2 hr. This step was followed by 10 rinses over a period of 5 hr to remove unbound '251-IgG. The tissue was then incubated with the GDH antiserum at a dilution of 1:2000 for 48 hr in the presence of 0.2% Triton X-100. All dilutions and washes were in Tris-saline (pH 7.6) containing 1% goat serum, and the entire labeling procedure was carried out at room temperature, with continuous agitation. The immunoreactivity for GDH was detected by the accumulation of peroxidase products, and the immunoreactivity for GFAP was detected autoradiographically. For the purpose of autoradiography, after the PAP reaction sections were mounted on slides, dehydrated, then rehydrated through ethanol and dipped in Ilford L4 emulsion (at 50°C) diluted 1: 1 with distilled water. These slides were air-dried, then stored with a desiccant in light-tight boxes at 4°C for 4-24 d exposure periods. The autoradiographs were developed at the end of the exposure period and examined with a Nikon Microphot FX using either bright-field or differential-interference contrast optics. The extent of labeling of the rabbit GFAP antiserum by the rabbit PAP was monitored by examining sections that were processed as described above in the absence of the GDH antiserum.
Other cytochemical and histochemical methods. Sections adjacent to the ones used for immunocytochemistry were processed for cytochemical and histochemical procedures to facilitate neuroanatomical identification of the immunoreactive structures. The histochemical procedure for the demonstration of AChE has been described previously by Hedreen et al. (1985) .
Presentation of labeling with the GDH antiserum. The immunoreactive structures were mapped using a camera lucida attachment on a Leitz microscope. The boundaries of nuclei and fiber tracts, which were difficult to distinguish on the immunocytochemically stained sections, were delineated using both adjacent Nissl and AChE-stained sections. Nomenclature for the nuclei and fiber tracts was from the atlas of Paxinos and Watson (1982) . In addition, identifications of some of the thalamic nuclei and neocortical regions were modified in accordance with the delineation of boundaries of Jones (1985) and Peters and Jones (1984) . Each stippling on the schematics of Fig. 6 , A-J, represents lo-15 processes. When the processes appeared to be regularly oriented within structures, stippled lines were drawn to reflect the direction of the labeled profiles.
Results
Under a specific set of experimental labeling conditions, GDH was selectively localized to glial cells. These GDH-enriched glial cells were heterogeneously distributed in rat brain. The experimental labeling conditions, morphological and chemical characteristics of identified glial cells, and distribution of the labeled cells are described in the following sections.
Labeling conditions
Vibratome sections of brains fixed with paraformaldehyde alone or combined with low (O.l-0.2%) concentrations of glutaraldehyde showed immunocytochemical labeling with GDH antiserum. Intense immunoreactivity was seen in glial cells when 0.2% Triton X-100 was included in all incubations ( Fig. 1 , A, C, E) (see next section for identity of cell types). Changes in the fixation condition, sectioning procedure, and use of lipid solvents markedly altered the intensity of the glial labeling for GDH.
For example, omission of glutaraldehyde increased, whereas addition of acrolein decreased, the intensity of labeling in Vibratome sections with the use of Triton X-100 in all incubations. In brains fixed with 4% paraformaldehyde, frozen and sectioned on a sliding microtome, and immunostained in the presence of T&on X-100, the peroxidase product in glia was greatly reduced. The substitution of saponin for T&on X-100 in the immunocytochemical labeling of paraformaldehyde-fixed Vibratome sections also produced less intense labeling in glia. In the absence of Triton X-100, similarly prepared sections showed only a diffuse background labeling and a low intensity of immunoreactivity in larger cells, presumed to be neuronal perikarya, in the striatum and in most other regions ( Fig. 1 , B, F). However, in areas such as the neocortex, the labeling in the cytoplasm of neuronal perikarya was more intense and pun&ate, particularly with higher concentrations (0.2%) of glutaraldehyde ( Fig. 1D ). Both glial and neuronal labeling were abolished when the primary antiserum was adsorbed with purified GDH prior to the immunocytochemical labeling ( Fig.  1 , G, H) and thus represented specific labeling for the enzyme.
Identification of glial cells
In Vibratome sections of paraformaldehyde-fixed tissues immunolabeled for GDH in the presence of Triton X-100, intense peroxidase reaction product was detected in round or spindleshaped cells having a thin rim of cytoplasm, multiple long (1 O-50 pm) branched processes, and small round or angular nuclei ( Fig. 1 , A, C', E). These cytological features, combined with their location in cellular portions of the neuropil and in fiber bundles, led to a tentative identification of protoplasmic and fibrous astrocytes (Figs. 1-6; described below in detail). Other presumed glial processes containing immunoreactivity for GDH were seen exclusively in areas, such as layer I of the anterior cingulate cortex (ACg; Fig. 2 , A, C). These straight, twiglike processes were lo-20 wrn in length, and clustered in tight bundles containing 3-5 processes.
The GDH-labeled processes along blood vessels were in a processes, as seen at low (Fig. 2 , A, B) and high ( Fig. 2 , C, D) magnifications of the ACg. However, the GDH-labeled cells and processes were far less numerous than those labeled with the GFAP antiserum in most areas examined. For example, in the ACg (Fig. 2B ) and in the hippocampus, GFAP-immunoreactive cells were prominent throughout all layers. In contrast, labeling with the GDH antiserum was enriched in the superficial layers in the ACg (Figs. 2A and 6, B-D) and within the stratum lacunosum-moleculare of the hippocampus (Fig. 6 , E, F, just dorsal to the hippocampal fissure), particularly in association with the walls of major blood vessels. In other examples, the GFAP-labeled processes showed little structural resemblance to the straight, twiglike processes containing immunoreactivity for GDH (Fig. 2 , C vs E). The labeling pattern in the cerebellum was more dramatically divergent. The radiating processes of glia, especially within the outer molecular layer, but also within the granule cell layer, were prominently labeled with the GFAP antiserum ( Fig. 3B ). In contrast, labeling for GDH was more moderate and within the finer-caliber fibers of the molecular layer and diffuse within the granule cell layer (Fig. 3A) .
The dorsal medulla oblongata was one of the regions that exhibited a close correspondence between the patterns of labeling for GDH and GFAP. With both antisera, the labeling was intense within the nucleus of the solitary tract (NTS) and dropped sharply at the boundary to the motor nucleus of vagus (X) (Fig. 4, A, B) .
In dual-labeling studies with dilutions sufficient to differentiate the 2 rabbit antisera, GDH was shown to be colocalized with GFAP in subsets of cells located in the neuropil and in fiber bundles (Fig. 5) . The dual labeling was detected in both the radiating, branched processes (double arrows in Figs. 5, A, B, D, 8) and in straight, twiglike processes (single arrow in Fig.  54 ). In most cases, the silver grains that developed from the lZSI-IgG bound to the GFAP antiserum were concentrated over only a portion of the peroxidase-labeled GDH cells or processes. In every region examined, cells exhibiting only silver grains (GFAP), only peroxidase (GDH immunoreactivity; arrowheads in Fig. 5 , A, D) and both of the labels were found.
Distribution of GDH-labeled cells and processes Forebrain
In the forebrain, dense as well as sparse labeling for GDH was seen in different subregions of the (1) neocortex, (2) hippocampus, (3) basal ganglia, (4) other telencephalic subnuclei, (5) thalamus, (6) hypothalamus, as well as in (7) fiber tracts.
Neocortex. Immunolabeling within layer I and along orthogonally oriented large blood vessels decreased in the rostrocaudal direction. Specifically, the most prominent labeling was seen in the ACg (Fig. 6, B-D) , the primary olfactory cortex (PO), and tubercle (Tu) (Fig. 6, A-E) . Less labeling was found in the posterior cingulate (PCg; Fig. 6E ) and entorhinal (Ent; Fig. 6fl cortices and the subiculum (S; Fig. 6F ). These processes were morphologically distinct from the radiating processes that extended outward from the corpus callosum (cc) in layer VI (Fig.  6, A, B) . Hippocampus. Twiglike processes containing GDH immunoreactivity were densely distributed throughout the anteriorposterior extension of the stratum lacunosum-moleculare of the hippocampus (Fig. 6 , E, F, just dorsal to the hippocampal fissure). These processes were in close association with blood vessels that coursed parallel to the hippocampal fissure. A few more delicately branched processes with GDH immunoreactivity were seen throughout all layers of the hippocampus and the dentate gyrus (DG), and running in parallel with the axons in the alveus. Diffuse labeling for GDH was most evident in the stratum lacunosum-moleculare of CA1 and CA3, but was also detectable in the pyramidal cell layer of CA1 .
Basal ganglia and associated nuclei. In the neostriatum (caudate-putamen complex), GDH was localized to numerous cells with long, wispy processes (Figs. 1, A, E; 5D; 6, B-E) that were frequently associated with blood vessels coursing in an anteriorposterior direction. Occasionally, labeled twiglike processes could also be identified within the dorsolateral quadrant.
The medial-ventral quadrant of the striatal complex, corresponding to the accumbens nucleus (Acb; Fig. 6 , A, B), the ventral pallidum (VP; Fig. 6 , B-D) and nucleus basalis (B; Fig.  6D ), and the more lateral endopyriform nucleus (En; Fig. 6 , B-E) and claustrum (Cl; Fig. 6 , A-D), were particularly rich in processes with GDH immunoreactivity.
In contrast, the 'substantia innominata (SI; Fig. 60 ) and the nucleus of the anterior commissure (AC; Fig. 6 , C, D) were only moderately labeled. The processes with GDH immunoreactivity in the globus pallidus (GP) were as dense as those in the neostriatum, and were clumped within the neuropil between the large fiber bundles that coursed through the structure (Fig. 6, D, E) .
Other telencephalic nuclei. The basolateral amygdaloid complex (BL, BLV, BM, LA, Fig. 6E ) exhibited intense GDH immunoreactivity in evenly distributed, irregularly shaped cells and processes. In contrast, the corticomedial group (Me, ACo, PMCo; Fig. 6 , E, F) was sparsely labeled. One exception was the central nucleus (Ce; Fig. 6E ) of the corticomedial group, which exhibited more processes containing GDH immunoreactivity.
The septohippocampal nucleus (SHi; Fig. 6B ) contained an extremely dense plexus of twiglike processes with GDH immunoreactivity.
These processes were uniformly oriented in parallel to the fiber tracts running mediolaterally through the nucleus. With the exception of external portions of the nucleus of the diagonal band (DB), which also contained dense, twiglike processes with GDH immunoreactivity along the brain surface (Fig. 6C ) and dense labeling in the horizontal limb (HDB; Fig.  6D ), more delicate, branched processes of moderate distributions were seen in the related septal nuclei.
Thalamus. In the thalamus, numerous shaggy, branched processes and cell bodies immunolabeled for GDH had features of protoplasmic astrocytes. The most intensely labeled nuclei in the dorsal thalamus were the rhomboid (Rh), the central medial (CM), and the paracentral (PC) nuclei of the intralaminar group (Fig. 6E) . In the ventral thalamus, the reticular nucleus (Rt) and zona incerta (ZI) contained the densest collections of labeled cells (Fig. 6E) . The pattern of labeling in the neuropil of the of sections prepared as in B, except for a higher concentration ofglutaraldehyde. The GDH-labeling in ventral thalamus was broken up by the many fiber bundles of the thalamic radiation and fields of Forel. The subthalamic nucleus (Sb; Fig. 6E ) also contained an extensive plexus of labeled processes. The remaining thalamic nuclei contained moderate, low, or no detectable immunoreactivity for GDH.
Hypothalamus.
In the hypothalamus, the highest density of processes with GDH immunoreactivity was seen in the suprachiasmatic (Sch) and supraoptic (SO) nuclei (Fig. 60) . The labeled processes in these nuclei appeared more stippled or varicose than in other regions. More characteristic glia-like processes labeled with GDH were densely distributed in the dorsal hypothalamic area (DA; Fig. 6E ), and were somewhat less numerous in the rostra1 part of the medial and the lateral preoptic nuclei (MP and LPO; Fig. 60 ). As shown in Figure 6E , labeled processes were rarely detected in the remaining hypothalamic nuclei.
Fiber tracts. Some of the most intensely immunoreactive cells and processes were seen within fiber tracts in the forebrain; other tracts remained clearly unlabeled. The processes were numerous in the corpus callosum and external capsule (cc, gee, ec; Fig. 6 , A-G; Fig. lc) , internal capsule (ic; Fig. 6E ), anterior commissure (aca, ac, acp; Fig. 6 , A-C'), lateral olfactory tract (lo; Fig.  6 , A-D), dorsal fomix (Fig. 6E) , fimbria (fx, fi; Fig. 6 , D, E), optic tract (opt, oc, sox; Fig. 6 , D, E), and cerebral peduncle (cp; Fig. 6, F, G) . The fomix (f, fx; Fig. 6, D, E) , the stria medullaris (sm; Fig. 6D ), and the mammillothalamic tract were less densely labeled, while the rostra1 continuation of the superior cerebellar peduncle, the mammillotegmental tract, and the stria terminalis (st; Fig. 6 , D, E) had almost no detectable labeling. Finally, immunoreactivity for GDH was seen in processes within the medial lemniscus (ml; Fig. 6 , F-H) only in regions near pontine nuclei.
Midbrain
In the midbrain, only the central gray, substantia nigra, pontine nuclei, and a few nuclei in the reticular formation, along with selective fiber tracts, had noteworthy densities of processes or cells with GDH immunoreactivity.
In the central gray, immunoreactive processes were seen throughout the region, but the dorsal and caudal areas were more heavily labeled (CG, CGD, Fig. 6, F, G) . The labeled cells and processes in the substantia nigra (SNC, SNR, Fig. 6fl were almost exclusively restricted to the areas adjacent to the cerebral peduncles (cp), which were themselves heavily labeled (Fig. 68) .
The pontine nuclei (Pn), the afferent corticopontine fibers within the longitudinal fibers of the pons (lfp), and the efferent transverse fibers of the pons (tfp) all exhibited prominent labeling of cells and processes (Fig. 6G) . Some of the processes were like those in other heavily myelinated structures, such as the globus pallidus, and others were of the straight, twiglike morphology.
Among nuclear groups of the reticular formation, the cuneiform (Cnc Fig. 6G ) and lateral dorsal tegmental (LDTg; Fig.  6G ) nuclei exhibited densely labeled cells with radiating and sometimes varicose processes, while the dorsal and ventral parabrachial nuclei contained more modest densities of labeled cells.
Fiber tracts containing the highest density of immunoreactive cells and processes included the cerebral peduncle (cp; Fig. 6F ) and superior cerebellar peduncle (scp; Fig. 6G ). Two auditory pathways, i.e., the lateral lemniscus (11; Fig. 6G ) and the brachium of the inferior colliculus (bit; Fig. 6G ), contained a more moderate density of labeling.
Hindbrain
Reticular nuclei that project to the cerebellum, namely, the paramedian (PMn; Fig. 64 and lateral reticular (LRt; Fig. 6 , Z, J) nuclei of the medulla, as well as the reticulotegmental nucleus of the pons (RtTg; Fig. 6G ) (reviewed in Carpenter, 1978) contained high densities of cells and processes with immunoreactivity for GDH. The pyramidal tracts (py; Fig. 6 , H-J) and trapezoid body (tz; Fig. 6H ) continued to exhibit intensely immunoreactive processes through the level of decussation. The area of the tract of the central tegmentum and locus coeruleus were labeled moderately. Of the raphe complex, only the dorsal nuclei and the dorsal part of the median nuclei (DR and MR, Fig. 6G ) exhibited detectable levels of immunoreactivity in astrocyte-like cells or processes.
Intense labeling of glial processes in cranial nerves was restricted to the selective subnuclei and tracts associated with the trigeminal (spV, SpVO, SpVI, mV; Fig. 6 , G, H), facial (VII; Fig.  6H ), acoustic (VIIIn; Fig. 6ZZ ), and vagus (X; Fig. 6, I , .Z), including the nucleus ambiguus (Amb; Fig. 6 , Z, 4. Of the nuclei and fiber tracts of the dorsal column, the nucleus of the external cuneate (ECU; Fig. 6 , Z, J) contained the highest density of labeled processes within the brain. The cuneate nucleus (Cu; Fig. 6J ) and its fiber tract, and the gracilis nucleus (Gr; Fig. 65 ) and its fiber tract were also densely labeled.
The inferior olive complex (IO) was another structure where intensely GDH-immunoreactive processes were numerous. These processes were fasciculated and closely wrapped around fiber bundles (Fig. 6Z) . Of the inferior olive complex, the medial accessory olive (MAO; Fig. 6 , Z, J) exhibited particularly intense labeling for GDH in small branched processes.
Cerebellum
The cells and processes with GDH immunoreactivity were fairly evenly distributed throughout the rostrocaudal extent of the various folia ofthe cerebellar cortex (Fig. 6H) . The entire granule cell layer (GCL) exhibited a patchy, diffuse labeling. Processes with moderate intensity of GDH immunoreactivity were evident in the molecular layer. Many labeled processes resembled the fine varicose branches of Bergmann glia (called the "velate astrocytes" by Palay and Chan-Palay, 1974) . Labeling for GDH was also seen in other types of glial processes (Ramon y Cajal, 1911) that appeared to radiate from various depths within the entire thickness of the molecular layer and were particularly evident in the floculonodular lobules.
The deep cerebellar nuclei, i.e., the fastigial (Fas), the interpositus (Int), and the dentate (De) (Fig. 6ZZ) , contained equal and moderate densities of processes with GDH immunoreactivity. Many labeled processes coursed parallel to the bundles of axons in the white matter near the deep cerebellar nuclei. Other myelinated bundles of fibers in the cerebellum also contained numerous delicate, GDH-immunoreactive processes oriented parallel to their longitudinal axes.
Discussion
Characterization of the antigenic GDH The present detection of intense labeling of GDH in glia in aldehyde-fixed sections of rat brain, using an antiserum raised against bovine liver GDH, supports earlier evidence for a high degree of conservation of the molecular structure of the enzyme among various species (Smith et al., 1975) and organs (Chee et al., 1979) . However, the detection of immunoreactivity was highly dependent on the procedures used for tissue preparation. The optimal labeling seen in paraformaldehyde-fixed Vibratome sections using 0.2% Triton X-100 probably reflects the conditions necessary for the antisera to reach certain intramolecular antigenic sites or subcellular compartments with minimal diffusion of GDH. Lai et al. (1986) have shown that GDH in rat brain is present in mitochondrial and nuclear fractions. GDH in isolated mitochondria can be solubilized in 0.1% Triton X-100, while nuclear GDH is soluble only in elevated concentrations of Triton X-100 (0.3%) and salt (150 mM KCl). Colon et al. (1986) also found that rat brain contained at least 2 kinds of GDH, differing in their susceptibilities to detergent extraction. Our results are consistent with the possible existence of multiple forms of the enzyme. It seems likely that the nuclear fraction that was difficult to solubilize even in unfixed tissues was never made freely accessible to the antisera under the experimental conditions that yielded optimal cytoplasmic labeling of glia in the present study. However, because of intense labeling in the cytoplasm, nuclear labeling of glia may have been obscured. Alternatively, the antiserum used in the present study may also have recognized a form of GDH distinct from the nuclear form characterized by Lai et al. (1986) . Under the conditions of our study, the antisera may recognize primarily a Triton-insoluble GDH that is more GTP-, NADH/NADPH-, and heat-sensitive than is the soluble form, and which has been proposed to be "non-mitochondrial" (Colon et al., 1986) .
Glial versus neuronal localization of GDH The results of this study have shown that, in Triton-treated sections, GDH is primarily localized to cells having the morphological characteristics of astrocytes (Kosaka and Hama, 1986) . In certain processes, dual labeling with GDH and GFAP further supports the concept that many GDH-containing cells are astrocytes. However, certain processes showed only GFAP, while others were immunolabeled exclusively for GDH. This would not be unexpected, since immunoreactivity for GFAP is principally localized to large shafts of processes containing glial filaments (Kosaka and Hama, 1986) and GDH would more likely be distributed in fine ramifications of processes enveloping synapses. Methodological factors such as differences in penetration of antisera or more superficial detection of autoradiographic labeling probably also contribute to the differential detection of GDH and GFAP. In addition, GDH may be found in a relatively small population of astrocytes containing GFAP, and may also be detected in oligodendrocytes or microglia. There is evidence strongly suggesting that oligodendrocytes (GFAP-negative, galactocerebroside-positive) and astrocytes (GFAP-positive, galactocerebroside-negative) arise from a common progenitor cell (Raff et al., 1983) and retain common antigenic determinants even after maturation (Brenner et al., 1986) . Also, the matter of whether or not microglia arise from astrocytes or from blood monocytes remains unsettled (Miles and Chou, 1986; Schelper and Adrian, 1986) . In light of these reports, it would be of interest to determine the ontogeny of expression of the antigenic form of glial GDH in relation to the other marker proteins by means of immunocytochemical double-labeling. While the most intense reaction for GDH was seen in glial processes in the present study, neuronal soma with varying intensities of immunoreactivity also were detected whenever Triton X-100 was omitted from the labeling procedure. The lowintensity cytoplasmic labeling seen in virtually all neurons is probably attributable to levels of the enzyme associated with the metabolic pools of glutamate. More intense neuronal labeling for GDH in certain regions, such as the cerebral cortex, could be associated with the neurotransmitter L-glutamate, as described for glia in the next section.
The difficulty in detecting neuronal labeling for GDH in the presence of Triton X-100 is probably attributable to the masking of faint immunoreactivity in neurons by more intense labeling of glia or, alternatively, to the greater solubility of neuronal GDH or its association with lipids that are extracted bv detergents.
Distribution of GDH in relation to glutamatergic pathways Detailed rostrocaudal mapping of GDH-immunoreactive glial cells and processes in the present study revealed a distribution remarkably similar to known glutamatergic pathways. In the neocortex, we detected the highest densities of twiglike processes containing GDH immunoreactivity within layer I, particularly in the anterior pole, and also accompanying large, orthogonally oriented blood vessels through layer III. Corresponding with this pattern is the uptake of 3H-D-aspartate within cortical slices, which has been shown to be highest in layer I (Fonnum et al., 198 1) . These observations are further supported by Monaghan and Cotman's (1985) characterization of N-methyl-D-aspartatesensitive glutamate receptors and the characterization by Halpain et al. of 3H-glutamate receptors, which indicate the presence of a laminar distribution that is highest within superficial layers, more anteriorly than caudally. In the cerebellum, the laminar distribution of these receptors also closely matches the GDH distribution, and in the inferior colliculus, N-methyl-D-aspartate-sensitive glutamate receptor binding exhibits a dorsal-toventral downward gradient (Monaghan and Cotman, 1985) , much like the distribution of GDH-immunoreactive processes seen within this area. On the basis of the present results, the demonstrated glutamate receptor binding may include both glia and neurons within receptive regions.
The above and other studies have demonstrated convincingly that the neostriatum, the accumbens nucleus, and, to a lesser extent, the substantia nigra receive glutamatergic fibers from the frontal cortex, while the lateral septal nucleus receives glutamatergic fibers from the hippocampal formation, and the amygdala from the frontal, pyriform, and entorhinal cortices (reviewed in Fonnum, 1984) . In the present study, all of these areas demonstrated moderate to intense GDH immunoreactivity.
The high densities of glial processes with GDH immunoreactivity were detected in the intralaminar (rhomboid, central medial, and paracentral) and ventral (reticular nucleus and zona incerta) thalamic nuclei. The question of whether these areas are sites of termination or of origin remains unsettled (Streit, 1980; Rustioni and Cuenod, 1982) . In support of the theory that certain thalamic nuclei are termination sites for pathways containing L-glutamate are reports of high densities of N-methyl-D-aspartate-sensitive receptors in these ventral and midline nuclei (Monaghan and Cotman, 1985) .
Hindbrain areas that receive cortical afferents (reviewed in Carpenter, 1978) , namely, (1) the reticular nuclei (reticulotegmental, lateral reticular, and paramedian nuclei), (2) the sensory relay nuclei (gracile, cuneate, external cuneate, sensory trigeminal, and solitary tract nuclei), (3) the inferior olive, and (4) the pontine nuclei, exhibited dense populations of GDH-immunoreactive processes. In accordance with this, many corticofugal systems (reviewed in Streit, 1984) and cerebellar projecting pathways (reviewed in Ottersen and Storm-Mathisen, 1984 ) are believed to be glutamatergic. Our finding of large numbers of glial cells with GDH immunoreactivity in the intermediate and caudal portions of the medial nuclei of the solitary tracts is also consistent with electrophysiological evidence that suggests that L-glutamate is one of the neurotransmitters of afferent nerve fibers from arterial baroreceptors (Talman et al., 1980) . The brain stem reticular and sensory relay nuclei are reported to contain only moderate densities of glutamate receptors (Halpain et al., 1984; Monaghan and Cotman, 1985) which suggests that GDH immunoreactivity may reflect factors other than the degree of glutamatergic innervation. It is interesting that these areas do exhibit intense levels of another mitochondrial enzyme, cytochrome oxidase (Claude, 1946; Wong-Riley, 1976) , indicative of high levels of tonic synaptic activity (Wong-Riley et al., 1978 , Wong-Riley 1979 Aoki et al., 1987) . Conceivably, the neuronal activity may determine the rate of turnover of glutamate released from axon terminals.
The present localization of GDH in glia of presumed glutamatergic pathways supports recent studies on neuron-glia interactions (reviewed in Hertz et al., 1983) in maintaining the compartmentalization of metabolic and neurotransmitter pools of L-glutamate. Besides their well-documented role in the control of interstitial ion composition and volume (reviewed in Abbott, 1986) , astrocytes take up glutamate with a capacity that is higher than that of neurons (Huck et al., 1984) . Astrocytes, then, can convert the glutamate to a-ketoglutarate and return the product to the tricarboxylic acid cycle of neurons (Dennis and Clark, 1977) . Alternatively, the astrocytes may use glutamine synthetase to convert glutamate to glutamine for its return to the amino acid pool of astrocytes and neurons (Bradford et al., 1978) . The active uptake and metabolism of glutamate by astrocytes are consistent with the present detection of GDH in regions where L-glutamate is actively released by axon terminals.
Involvement of GDH in glutamate cytotoxicity Glutamate and its analogs, kainic and ibotenic acid are wellknown excitotoxins when present in excess amounts within glutamate-receptive areas (Van Harreveld and Fitkova, 197 l) , including the temporal lobe (Olney, 1985) and striatum (McGeer and McGeer, 1976; Coyle et al., 1977) . L-Glutamate also has been implicated in neurodegenerative changes following metabolic insults, such as hypoglycemia (Wieloch, 1985) and ischemia (Rothman, 1984; Simon et al., 1984) , since these damages can be prevented by prior, central applications of antagonists to glutamate receptors. As noted above, the hindbrain areas with the highest concentrations of GDH were structures that project to the cerebellum. These areas, together with the GDH-rich granule cell layer of the cerebellar cortex, characteristically undergo atrophy in extrapyramidal motor disorders of the olivopontocerebellar type (Yamaguchi et al., 1982; Duvoisin et al., 1983; Plaitakis et al., 1984) . As postulated by Plaitakis et al. (1984) , the high levels of GDH may be necessary for protection against glutamate cytotoxicity in areas having active glutamatergic neurotransmission. Thus, these areas would be expected to be the first to show neuronal degeneration following a systemic deficiency of GDH. GDH-deficient patients exhibit "multiple-system degeneration," suggestive of alterations of the caudate putamen and globus pallidus, the hippocampus and other limbic structures, the cortex, the oculomotor nerve, lateral vestibular nucleus, cerebellum, brain stem, frontal lobes, hypothalamic and thalamic areas. The present detection of high densities of GDH immunoreactivity in glial processes in all of these areas strongly supports the concept that degenerative changes in specific regions of the CNS may be associated with deficiencies of GDH. However, the reports of GDH deficiency in patients with multiple systems degeneration were based on measurements of GDH activity in leukocytes and fibroblasts. It would be of interest to confirm that the GDH activity within the CNS and, in particular, within the brain stem, pontine, and cerebellar areas is similarly deficient in these patients.
PCRt, parvocellular reticular n. Pe, periventricular n. of hypothalamus PFI, paraflocculus PMCo, posteromedial cortical n. of amygdala PMn, paramedian reticular n. PN, paranigral n. Pn, pontine n. PnO, pontine reticular n., oral PO, primary olfactory cortex PO, post. complex of thalamus PPT, post. pretectal n. PrH, prepositus hypoglossal n. PrS, presubiculum PV, paraventricular n. of epithalamus py, pyramidal tract R, red n. Re, reuniens n. of thalamus Rh, rhomboid n. of thalamus RLi, rostra1 linear n. of raphe RPa, raphe pallidus n. RMg, raphe magnus n. 
